fbpx

QQQ
-4.48
382.79
-1.18%
BTC/USD
+ 480.34
48218.16
+ 1.01%
DIA
-2.49
350.67
-0.72%
SPY
-5.78
452.95
-1.29%
TLT
-0.72
150.61
-0.48%
GLD
-0.25
164.28
-0.15%

Why Idera Shares Are Skyrocketing Today

June 22, 2021 3:53 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares are trading higher by 43% at $1.60 after it was disclosed in a Form 4 filing the company COO Daniel Soland purchased 50,000 shares of the company stock at an average price of $1.19.

Idera Pharmaceuticals is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases.

Idera Pharmaceuticals has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.

Idera Pharmaceuticals has a 52-week high of $6.14 and a 52-week low of $0.97

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

With More Than 100% Upside Seen In Idera Pharma Shares, Baird Initiates At Outperform

Exclusive: Idera CEO Discusses The Potential For His Company's Lead Drug Candidate

Idera Pharma Shares Could Be A Four-Bagger, JMP Says

Three Biotech Companies With Large Upside Potential